EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Cheminformatics-driven discovery of natural isoquinoline alkaloid inhibitors of Beta-secretase I for Alzheimer’s management

Iqra Ahmad, Sara Waheed, Bader S Alotaibi, Sumra Wajid Abbasi, Muhammad Umer Khan, Faiz Ur Rahman, Hanna Dib, Khaled Fahmi Fawy, Umar Nishan iD, Abid Ali, Aqal Zaman, Mohibullah Shah iD

PLOS One · 2026

DOI: 10.1371/journal.pone.0343717 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2026. Verfasst von Iqra Ahmad und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan. Hauptthemen laut MEDLINE: Amyloid Precursor Protein Secretases, Alzheimer Disease, Cheminformatics, Alkaloids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FUNCAP, King Khalid University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is characterized by the gradual deterioration of cognitive functions, speech impairment, and memory loss. It can potentially be treated by targeting the beta-site amyloid precursor protein cleavage enzyme 1 (BACE1), which plays a key role in amyloid plaque formation, neurofibrillary tangles, and hyperphosphorylated tau protein. Current drugs have limitations in terms of safety, efficacy, and blood-brain barrier permeability. In view of this, this study was designed to determine the potential inhibitors of the BACE1 enzyme by virtual screening using a curated library of 415 natural products including terpenoids, phenolic compounds, and alkaloids from different medicinal plants. Based on the docking score and interaction analysis, 50 compounds were selected for the downstream analysis, such as ligand binding interactions, pharmacokinetics, druglikness and physicochemical parameters. Among the lead compounds, Palmatine (compound 45) and Berberine (compound 49), demonstrated optimal drug-likeness and blood-brain barrier permeability among the top compounds. 2-[(9Z,12Z)-heptadeca-9,12-dienyl]-6-hydroxybenzoic acid (compound 4) was inactive in most toxicity parameters. Pharmacophore analysis revealed that Palmatine and Berberine share similar features with the standard, highlighting their potential as effective compounds. Furthermore, structural chemistry analysis provided insights on their shared isoquinoline alkaloid framework, illustrating their structural similarities. Molecular dynamics simulations confirmed the stability of the Palmatine-BACE1 and Berberine-BACE1 complexes during a 50 ns production run. Overall, these findings highlighted the potential of Palmatine and Berberine as promising candidates for the experimental validation and the development of the drugs for the treatment of AD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Amyloid Precursor Protein SecretasesAlzheimer DiseaseCheminformaticsAlkaloidsAspartic Acid EndopeptidasesIsoquinolinesBiological ProductsHumansMolecular Docking SimulationBlood-Brain BarrierDrug DiscoveryPharmacophoreBerberine

Substanzen

Amyloid Precursor Protein SecretasesAlkaloidsAspartic Acid EndopeptidasesIsoquinolinesBACE1 protein, humanBiological ProductsBerberine

Autor:innen und Institutionen

  • Department of Biochemistry, Bahauddin Zakariya University, Multan, Pakistan.
  • Department of Clinical Laboratory Sciences, College of Applied Medical Sciences, Al- Quwayiyah, Shaqra University, Riyadh, Saudi Arabia.
  • Department of Biological Sciences, National University of Medical Sciences, Rawalpindi, Pakistan.
  • Institute of Molecular Biology and Biotechnology, The University of Lahore, Lahore, Pakistan.
  • Department of Zoology, University of Shangla, Swat, Khyber Pakhtunkhwa, Pakistan.
  • College of Engineering and Technology, American University of the Middle East, Kuwait.

ORCID-Profile: Umar Nishan, Mohibullah Shah

Förderung

  • FUNCAP
  • King Khalid University

Zitieren

APA

Ahmad, I., Waheed, S., Alotaibi, B. S., Abbasi, S. W., Khan, M. U., Rahman, F. U., Dib, H., Fawy, K. F., Nishan, U., Ali, A., Zaman, A., & Shah, M. (2026). Cheminformatics-driven discovery of natural isoquinoline alkaloid inhibitors of Beta-secretase I for Alzheimer’s management. PLOS One. https://doi.org/10.1371/journal.pone.0343717

Vancouver

Ahmad I, Waheed S, Alotaibi BS, Abbasi SW, Khan MU, Rahman FU, et al. Cheminformatics-driven discovery of natural isoquinoline alkaloid inhibitors of Beta-secretase I for Alzheimer’s management. PLOS One. 2026. doi:10.1371/journal.pone.0343717

BibTeX
@article{Ahmad2026,
  author = {Ahmad, Iqra and Waheed, Sara and Alotaibi, Bader S and Abbasi, Sumra Wajid and Khan, Muhammad Umer and Rahman, Faiz Ur and Dib, Hanna and Fawy, Khaled Fahmi and Nishan, Umar and Ali, Abid and Zaman, Aqal and Shah, Mohibullah},
  title = {Cheminformatics-driven discovery of natural isoquinoline alkaloid inhibitors of Beta-secretase I for Alzheimer’s management},
  journal = {PLOS One},
  year = {2026},
  doi = {10.1371/journal.pone.0343717}
}
Kostenlos starten →